Cadrenal Therapeutics, Inc. (CVKD) › Weighted Average Diluted SharesCadrenal Therapeutics, Inc. (CVKD) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2023-12-31: 899.5K2024-12-31: 1.22M2025-12-31: 1.99M1.99M2023-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-311.99M+63.5%2026-03-31From 2025-01-012024-12-311.22M+35.6%2026-03-31From 2024-01-012023-12-31899.5K—2025-03-13From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)